RecruitingNot ApplicableNCT07144007
Prevention of Emergence Agitation in Rhinoplasty With Subanesthetic Propofol and Single-Dose Dexmedetomidine: A Prospective Double-Blind Clinical Study
Van Yuzuncu Yil University Faculty of Medicine Ethics Committee
Sponsor
Yuzuncu Yil University
Enrollment
80 participants
Start Date
Apr 15, 2025
Study Type
INTERVENTIONAL
Summary
To compare of prevention of emergence agitation in rhinoplasty with subanesthetic propofol and single dose dexmedetomidine
Eligibility
Min Age: 18 YearsMax Age: 65 Years
Inclusion Criteria3
- Patients scheduled for rhinoplasty
- Between 18-65 years
- ASA I-II group
Exclusion Criteria5
- Those who are outside the age range of 18-65
- Those who are ASA III and above
- Those with renal,hepatic, cardiac and respiratory diseases
- Those with a known allergy to the medication to be used
- Those who underwent urinary catheterization
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGDexmedetomidine
In rhinoplasty, 10 minute infusion of 0,5 mcg/kg dexmedetomidine will be administered after nasal packing
DRUGPropofol
In rhinoplasty, 0,5 mg/kg propofol IV bolus will be administered after nasal packing
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07144007